JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huotari, M.
Right arrow Articles by Männistö, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huotari, M.
Right arrow Articles by Männistö, P. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

Vol. 303, Issue 3, 1309-1316, December 2002

Effect of Dopamine Uptake Inhibition on Brain Catecholamine Levels and Locomotion in Catechol-O-methyltransferase-Disrupted Mice

Marko Huotari, Miklos Santha, Louis R. Lucas, Maria Karayiorgou, Joseph A. Gogos and Pekka T. Männistö

Department of Pharmacology and Toxicology, University of Kuopio, Kuopio, Finland (M.H., P.T.M.); The Rockefeller University, New York, New York (M.S., L.R.L., M.K.); and Department of Physiology and Cellular Biophysics and Center for Neurobiology and Behavior, College of Physicians and Surgeons, Columbia University, New York, New York (J.A.G.)

Two different uptake processes terminate the synaptic action of released catecholamines in brain: the high-affinity uptake to presynaptic nerve terminals (uptake1, followed by oxidation by monoamine oxidase, MAO) or glial cells uptake (uptake2, followed by O-methylation by catechol-O-methyltransferase, COMT, and/or oxidation by MAO). For dopaminergic neurons, uptake by the high-affinity dopamine transporter (DAT) is the most effective mechanism, and the contribution of glial COMT remains secondary under normal conditions. In the present study we have characterized the role of COMT using COMT-deficient mice in conditions where DAT is inhibited by 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-piperazine (GBR 12909) or cocaine. In mice lacking COMT, GBR 12909 results in total brain tissue dopamine levels generally higher than in wild-type mice but no such potentiation was ever seen in striatal extracellular fluid. Dopamine accumulation in nerve endings is more evident in striatum and hypothalamus than in cortex. Both GBR 12909 and cocaine induced hyperlocomotion in mice lacking COMT. Unexpectedly, hyperactivity induced by 20 mg/kg GBR 12909 was attenuated only in male COMT knockout mice, i.e., they had an inability to sustain the hyperactivity induced by DAT inhibition. Furthermore, attenuation of hyperlocomotion was observed also after cocaine treatment in both C57BL/6 (at 5 and 15 mg/kg) and 129/Sv (at 30 mg/kg) genetic background COMT-deficient male mice. Despite the possible interaction between DAT and extraneuronal uptake (and subsequently COMT), the role of COMT in dopamine elimination is still minimal in conditions when DAT is inhibited.


0022-3565/02/3033-1309$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Du, M. Schwander, E. M. Y. Moresco, P. Viviani, C. Haller, M. S. Hildebrand, K. Pak, L. Tarantino, A. Roberts, H. Richardson, et al.
A catechol-O-methyltransferase that is essential for auditory function in mice and humans
PNAS, September 23, 2008; 105(38): 14609 - 14614.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
U. M. Kramer, T. Cunillera, E. Camara, J. Marco-Pallares, D. Cucurell, W. Nager, P. Bauer, R. Schule, L. Schols, A. Rodriguez-Fornells, et al.
The Impact of Catechol-O-Methyltransferase and Dopamine D4 Receptor Genotypes on Neurophysiological Markers of Performance Monitoring
J. Neurosci., December 19, 2007; 27(51): 14190 - 14198.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yacubian, T. Sommer, K. Schroeder, J. Glascher, R. Kalisch, B. Leuenberger, D. F. Braus, and C. Buchel
Gene gene interaction associated with neural reward sensitivity
PNAS, May 8, 2007; 104(19): 8125 - 8130.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
T. Demiralp, C. S. Herrmann, M. E. Erdal, T. Ergenoglu, Y. H. Keskin, M. Ergen, and H. Beydagi
DRD4 and DAT1 Polymorphisms Modulate Human Gamma Band Responses
Cereb Cortex, May 1, 2007; 17(5): 1007 - 1019.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bertolino, G. Blasi, V. Latorre, V. Rubino, A. Rampino, L. Sinibaldi, G. Caforio, V. Petruzzella, A. Pizzuti, T. Scarabino, et al.
Additive Effects of Genetic Variation in Dopamine Regulating Genes on Working Memory Cortical Activity in Human Brain
J. Neurosci., April 12, 2006; 26(15): 3918 - 3922.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. H. Schott, C. I. Seidenbecher, D. B. Fenker, C. J. Lauer, N. Bunzeck, H.-G. Bernstein, W. Tischmeyer, E. D. Gundelfinger, H.-J. Heinze, and E. Duzel
The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging
J. Neurosci., February 1, 2006; 26(5): 1407 - 1417.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.